Plus Therapeutics (PSTV) EBITDA Margin Growth (3y) (2014 - 2026)
Plus Therapeutics (PSTV) EBITDA Margin Growth (3y) (2014 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBITDA Margin Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
788,338.31 Bn |
788,338.28 Bn |
- |
- |
| 2 |
Belite Bio |
56,560.00 Bn |
56,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,329.30 Bn |
17,329.30 Bn |
- |
- |
| 4 |
Legend Biotech |
3,341.00 Bn |
3,340.71 Bn |
242.10 Mn |
-40,178.00 |
| 5 |
Akari Therapeutics |
1,727.91 Bn |
1,727.91 Bn |
- |
- |
| 6 |
Evaxion A |
1,536.68 Bn |
1,536.67 Bn |
- |
- |
| 7 |
Psyence Biomedical |
238.34 Bn |
238.33 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.42 Bn |
106.17 Bn |
2.59 Bn |
530.00 |
| 9 |
Abivax |
95.45 Bn |
95.45 Bn |
- |
- |
| 10 |
Plus Therapeutics |
34.26 Mn |
19.15 Mn |
- |
25,189.00 |
| Date | Value |
|---|
| Mar 31, 2026 |
25,189.00 |
| Dec 31, 2025 |
396,736.00 |
| Sep 30, 2025 |
665,725.00 |
| Mar 31, 2019 |
-4,879.00 |
| Dec 31, 2018 |
2,704.00 |
| Sep 30, 2018 |
-49,168.00 |
| Jun 30, 2018 |
-82,358.00 |
| Mar 31, 2018 |
178,879.00 |
| Dec 31, 2017 |
-39,590.00 |
| Sep 30, 2017 |
77,467.00 |
| Jun 30, 2017 |
61,859.00 |
| Mar 31, 2017 |
-27,305.00 |
| Dec 31, 2016 |
6,055.00 |
| Sep 30, 2016 |
-39,654.00 |
| Jun 30, 2016 |
-35,772.00 |
| Mar 31, 2016 |
13,949.00 |
| Dec 31, 2015 |
-8,535.00 |
| Sep 30, 2015 |
106,972.00 |
| Jun 30, 2015 |
69,391.00 |
| Mar 31, 2015 |
-180,073.00 |
